Treatment coverage is not certified in this packet.

Diagnostic methods are not certified in this packet.

Prognosis is not certified in this packet.

Certified active trial records are present for this condition, and several are listed. One is NCT07313618, an Early Phase 1 study titled Safety and Efficacy of a Single Suprachoroidal Injection of JWK010 Gene Therapy in Subjects With Oculocutaneous Albinism Type 1 (OCA1) (recruiting; West China Hospital). Others include NCT06138509, Peripheral Serotonin and Albinism (recruiting; Assistance Publique - Hopitaux de Paris), and NCT06345976, Functional Impairment in Albinism (recruiting; Fondation Ophtalmologique Adolphe de Rothschild). Broader registry and sequencing studies that include rare inherited ophthalmic diseases or genodermatoses also appear, such as NCT06491615, the National Ophthalmic Genotyping and Phenotyping Network, Stage 3 (recruiting; National Eye Institute), and NCT06330350, a qualitative study on reproductive counselling in genodermatoses (recruiting; Maastricht University Medical Center). A title does not establish the intervention studied or its efficacy. Active clinical trials for this condition are listed on ClinicalTrials.gov.